Barriers of Thrombolysis Therapy in Developing Countries

The developing world carries the highest burden of stroke mortality and stroke-related disability. The number of stroke patients receiving r-tPA in the developing world is extremely low. Prehospital delay, financial constraints, and lack of infrastructure are main barriers of thrombolysis therapy in...

Full description

Saved in:
Bibliographic Details
Main Author: Kavian Ghandehari
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Stroke Research and Treatment
Online Access:http://dx.doi.org/10.4061/2011/686797
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849397346946777088
author Kavian Ghandehari
author_facet Kavian Ghandehari
author_sort Kavian Ghandehari
collection DOAJ
description The developing world carries the highest burden of stroke mortality and stroke-related disability. The number of stroke patients receiving r-tPA in the developing world is extremely low. Prehospital delay, financial constraints, and lack of infrastructure are main barriers of thrombolysis therapy in developing countries. Until a cheaper thrombolytic agent and the proper infrastructure for utilization of thrombolytic therapy is available, developing countries should focus on primary and secondary stroke prevention strategies. However, governments and health systems of developing countries should efforts exerb for promotion of their infrastructure of stroke care.
format Article
id doaj-art-aed62e3c9ee14b83b3ca6a51ce16f65d
institution Kabale University
issn 2042-0056
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Stroke Research and Treatment
spelling doaj-art-aed62e3c9ee14b83b3ca6a51ce16f65d2025-08-20T03:39:03ZengWileyStroke Research and Treatment2042-00562011-01-01201110.4061/2011/686797686797Barriers of Thrombolysis Therapy in Developing CountriesKavian Ghandehari0Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, P.O. Box: 91766-99199, IranThe developing world carries the highest burden of stroke mortality and stroke-related disability. The number of stroke patients receiving r-tPA in the developing world is extremely low. Prehospital delay, financial constraints, and lack of infrastructure are main barriers of thrombolysis therapy in developing countries. Until a cheaper thrombolytic agent and the proper infrastructure for utilization of thrombolytic therapy is available, developing countries should focus on primary and secondary stroke prevention strategies. However, governments and health systems of developing countries should efforts exerb for promotion of their infrastructure of stroke care.http://dx.doi.org/10.4061/2011/686797
spellingShingle Kavian Ghandehari
Barriers of Thrombolysis Therapy in Developing Countries
Stroke Research and Treatment
title Barriers of Thrombolysis Therapy in Developing Countries
title_full Barriers of Thrombolysis Therapy in Developing Countries
title_fullStr Barriers of Thrombolysis Therapy in Developing Countries
title_full_unstemmed Barriers of Thrombolysis Therapy in Developing Countries
title_short Barriers of Thrombolysis Therapy in Developing Countries
title_sort barriers of thrombolysis therapy in developing countries
url http://dx.doi.org/10.4061/2011/686797
work_keys_str_mv AT kavianghandehari barriersofthrombolysistherapyindevelopingcountries